CervoMed Inc. is a biotechnology company focused on the development of innovative therapies for neurological disorders. The company is dedicated to advancing its proprietary technologies to address a range of unmet medical needs in the field of neurodegenerative diseases. Through rigorous research and clinical trials, CervoMed seeks to improve the lives of patients suffering from conditions that affect the nervous system, aiming to bring transformative solutions to the healthcare market. Read More
Neflamapimod endorsement based on targeted mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging translational data in ALS-relevant neurotoxicity models
Peraso Inc. (NASDAQ: PRSO), a leader in 60GHz mmWave wireless technology, is rapidly expanding its global footprint through dual momentum in defense and broadband sectors. In a key commercial milestone, Tachyon Networks has selected Peraso’s PRM2141X module for its new TNA-303L-65 —a compact outdoor wireless solution delivering fiber-class speeds up to 1 Gbps across 3+ km, without the need for costly trenching.
